高雄激素型多囊卵巢综合征女性2型糖尿病风险更高
基于瑞典六国登记库的队列研究,纳入52,535例多囊卵巢综合征(PCOS)女性及254,624名年龄和地区匹配的对照女性,随访最长19年。结果显示PCOS是2型糖尿病(T2D)的独立危险因素,校正BMI后风险仍高2倍;高雄激素(HA)表型者T2D风险显著高于正常雄激素(NA)表型。
要点
- PCOS女性T2D累积发病率高于非PCOS女性,且HA表型者最高。
- 校正BMI后PCOS仍使T2D风险增加约2.5倍,属独立危险因素。
- HA表型PCOS女性T2D风险显著高于NA表型,需更积极筛查。
核心结论
- PCOS是T2D的独立危险因素,校正BMI后风险仍升高。
- 高雄激素型PCOS女性的T2D风险高于正常雄激素型。
研究设计与样本
- 基于人群的队列研究,数据来自瑞典六个国家登记库,随访最长19年。
- 纳入1950至1999年出生、诊断为PCOS、雄激素过多或无排卵性不孕的女性52,535例。
- 按年龄和地区匹配随机选取对照女性254,624名。
- 高雄激素PCOS表型定义为两次开具抗雄激素药物处方。
主要发现
- T2D累积发病率在对照、NA PCOS和HA PCOS女性中分别为1.3%、4.4%和14.2%。
- 校正BMI后,PCOS女性T2D发生率是非PCOS女性的2倍(校正风险比2.52,95%CI 2.15-2.96)。
- HA PCOS女性T2D发生率高于NA PCOS女性(校正风险比3.86,95%CI 3.16-4.72)。
关键数值与推荐
- T2D结局定义为ICD-10诊断或除二甲双胍外的抗糖尿病治疗处方。
- HA PCOS表型定义为两次抗雄激素药物处方记录。
临床怎么用
- 对PCOS女性应关注T2D风险,尤其高雄激素表型者。
- 即使BMI正常,PCOS女性仍需考虑T2D筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the risk of type 2 diabetes (T2D) in women with polycystic ovary syndrome (PCOS) in relation to body mass index (BMI) and the hyperandrogenic (HA) PCOS phenotype. DESIGN: Population-based cohort study. SETTING: Data from six Swedish national registers, with participants being followed for a maximum of 19 years. PATIENT(S): All women with an International Statistical Classification of Diseases and Related Health Problems, version 10, diagnosis of PCOS, androgen excess, or anovulatory infertility born between 1950 and 1999 (n = 52,535) were identified in the Patient Register. The HA PCOS phenotype was defined by two filled prescriptions for anti-androgenic drugs. For each woman with PCOS, five control women (n = 254,624) were randomly chosen from the Total Population Register, matched for age and geographic area. INTERVENTION(S): No interventions were performed. MAIN OUTCOME MEASURE(S): International Statistical Classification of Diseases and Related Health Problems, version 10, diagnosis of T2D or prescription of antidiabetic treatment other than metformin. RESULT(S): The cumulative incidence rates of T2D were 1.3%, 4.4%, and 14.2% in controls (non-PCOS women) and women with normoandrogenic (NA) and HA PCOS, respectively. After adjustment for BMI, women with PCOS had a twofold higher rate of T2D than non-PCOS women (adjusted hazard ratio, 2.52 [95% confidence interval, 2.15-2.96]). Women with HA PCOS had a higher rate of T2D than those with NA PCOS (adjusted hazard ratio, 3.86 [95% confidence interval, 3.16-4.72]). CONCLUSION(S): Polycystic ovary syndrome is an independent risk factor for T2D, even after adjustment for BMI. Women with the HA PCOS phenotype face an even higher risk of T2D than those with the NA PCOS phenotype.
引用
- Persson S, Elenis E, Turkmen S, et al. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome. Fertil Steril. 2021. PMID: 34053678. doi:10.1016/j.fertnstert.2021.04.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。